Össur hf: Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer
Announcement no. 40/2022
11 July 2022
Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer
Gudny Arna Sveinsdottir has been appointed Chief Financial Officer (CFO) of Össur and will join the Össur Executive Committee on 1 September 2022. Mrs. Sveinsdottir held finance roles at Kvika Bank and subsidiaries for the past year, and prior to that, she was at Teva Pharmaceuticals/Actavis for ten years, including as the CFO of Teva Pharmaceutical Generic R&D. During her time at Teva, she worked and lived in Switzerland and in the US. Mrs. Sveinsdottir was an independent consultant to financial institutions in Iceland before joining Teva and worked in various finance roles at Kaupthing Bank 2001-2008, including as the CFO. Prior to that, she worked at Eimskip in Iceland and PWC in Stockholm. Mrs. Sveinsdottir has a Master’s degree in Accounting and Finance from the University of Uppsala in Sweden and a Cand.oecon. degree from the University of Iceland.
“We are very pleased to have Gudny Arna Sveinsdottir join Össur as our CFO. Her financial acumen and extensive experience, coupled with her collaborative mindset and impressive leadership skills, will complement our performance-oriented culture. We look forward to welcoming Mrs. Sveinsdottir in her new role,“ said Sveinn Sölvason, President and CEO of Össur.
Further information
Edda Lára Lúðvígsdóttir, Investor Relations Director, [email protected], +354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized “Technology Pioneer” with a rich 50-year history, Össur focuses on improving people’s mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com